tm
Seeing Is Believing
tm
Seeing Is Believing
MREO is currently covered by 2 analysts with an average price target of $5.98. This is a potential upside of $3.2 (115.11%) from yesterday's end of day stock price of $2.78.
Mereo BioPharma Group PLC ADR's activity chart (see below) currently has 0 price targets and 9 ratings on display. The stock rating distribution of MREO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 169.5 days.
Highest price target for MREO is $7, Lowest price target is $6, average price target is $5.98.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 28-Mar-2024. First documented stock forecast 12-Aug-2022.
Currently out of the existing stock ratings of MREO, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$3.22 (115.83%)
5
28 days ago
0/5 (0%)
$2.7 (81.82%)
Buy
7
$4.22 (151.80%)
4
28 days ago
2/3 (66.67%)
$3.7 (112.12%)
339
What is MREO (Mereo BioPharma Group PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on MREO (Mereo BioPharma Group PLC ADR) with a proven track record?
Which analyst has the current lower performing score on MREO (Mereo BioPharma Group PLC ADR) with a proven track record?
Which analyst has the most public recommendations on MREO (Mereo BioPharma Group PLC ADR)?
Which analyst is the currently most bullish on MREO (Mereo BioPharma Group PLC ADR)?
Which analyst is the currently most reserved on MREO (Mereo BioPharma Group PLC ADR)?
